ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,802Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 617

$646K Total Retail Price of All Prescriptions

Rank: 36 out of 617

454 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 12,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 645 588 1 1
WARFARIN SODIUM 544 511 2 7
OMEPRAZOLE 509 436 3 3
FUROSEMIDE 485 460 4 4
LISINOPRIL 428 398 5 5
SIMVASTATIN 418 382 6 2
TRAMADOL HCL 405 341 7 15
CRESTOR 400 364 8 28
AMLODIPINE BESYLATE 386 381 9 6
POTASSIUM CHLORIDE 326 306 10 10
LOSARTAN POTASSIUM 265 253 11 22
DONEPEZIL HCL 255 255 12 30
NAMENDA 229 229 13 35
CARBIDOPA-LEVODOPA 228 180 14 69
METFORMIN HCL 210 164 15 9
ESCITALOPRAM OXALATE 198 198 16 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 195 178 17 29
HYDROCODONE-ACETAMINOPHEN 174 129 S3 18 8
METOPROLOL TARTRATE 168 162 19 11
CYMBALTA 168 138 19 49
DIGOXIN 165 165 21 48
PREDNISONE 153 139 22 31
SERTRALINE HCL 151 145 23 20
ATORVASTATIN CALCIUM 149 119 24 14
CARVEDILOL 142 140 25 19
TAMSULOSIN HCL 133 133 26 26
ISOSORBIDE MONONITRATE ER 126 120 27 52
GABAPENTIN 126 114 27 16
FENOFIBRATE 122 110 29 58
PAROXETINE HCL 115 115 30 62
BYSTOLIC 110 110 31 64
FLUTICASONE PROPIONATE 108 89 32 36
CLONIDINE HCL 105 93 33 55
QUETIAPINE FUMARATE 104 101 34 78
PANTOPRAZOLE SODIUM 103 86 35 37
MIRTAZAPINE 99 87 36 50
DILTIAZEM ER 99 79 36 81
HYDROCHLOROTHIAZIDE 97 90 38 13
METOPROLOL SUCCINATE 93 81 39 12
NEXIUM 93 84 39 43
CITALOPRAM HBR 89 88 41 18
GLIMEPIRIDE 84 84 42 33
MELOXICAM 83 63 43 24
FAMOTIDINE 83 74 43 54
LYRICA 80 62 45 92
CELEBREX 80 75 45 63
ZOLPIDEM TARTRATE 78 45 47 23
AMITRIPTYLINE HCL 76 74 R 48 56
DIOVAN 70 67 49 41
DIOVAN HCT 70 63 49 97
ALLOPURINOL 64 55 51 27
RISPERIDONE 63 39 52 71
ALENDRONATE SODIUM 62 60 53 25
LANTUS 61 47 54 39
CLOPIDOGREL 61 61 54 53
TRIAMTERENE-HCTZ 60 60 56 47
ROPINIROLE HCL 56 51 57 66
FENTANYL 56 46 S2 57 45
SPIRIVA 55 38 59 61
PLAVIX 55 55 59 86
VENLAFAXINE HCL ER 54 54 61 76
OXYBUTYNIN CHLORIDE 52 52 62 88
ATENOLOL 50 50 63 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.